Kenyan citizens are alarmed by a potential breach of trust! The government's plan to share sensitive health data with the US has sparked intense debate, leaving many questioning the implications.
A controversial agreement between the Kenyan and US governments has caused an uproar. Critics argue that President William Ruto is about to sign a deal that could compromise the privacy and sovereignty of Kenyan citizens. But here's the catch: the agreement might grant the US unprecedented access to Kenya's health database, potentially bypassing Kenyan laws.
The agreements, known as the Model Specimen Sharing Agreement and the PEPFAR Bilateral MOU, are said to provide the US with real-time access to patient-level data, including diagnostics and sequencing, often without anonymization or individual consent. And this is the part most people miss: the deal would be governed by US federal law, not Kenyan law, which raises concerns about legal jurisdiction.
Furthermore, Kenya would be obligated to deliver disease specimens to the US within a mere 5 days of request. US pharmaceutical companies could develop vaccines from these specimens, but there's no guarantee of reciprocal benefits for Kenya. The agreement hints at consequences if commitments are not met, leaving Kenya in a potentially vulnerable position.
The US would gain direct access to query patient records, audit health facilities, and obtain lab results, treatment data, and more. Dr. Mugambi Laibuta warns that these deals pose significant constitutional risks and require renegotiation.
This situation begs the question: Is this agreement a fair exchange, or does it threaten the privacy and autonomy of Kenyan citizens? Share your thoughts below!
